Serum procalcitonin in cirrhotic patients with septic shock: Relationship with adrenal insufficiency and clinical outcomes

Clinical Laboratory

Volumn 60, Issue 7, 2014, Pages 1105-1114

  Al Dorzi, Hasan M ^a   Rishu, Asgar H ^a   Tamim, Hani M ^a   Aljumah, Abdulrahman ^a   Al Tamimi, Waleed ^a   Baharoon, Salim ^a   Al Dabbagh, Tarek ^a   Arabi, Yaseen M ^a  

^a KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

Author keywords

Adrenal insufficiency; Cirrhosis; Critical illness; Procalcitonin; Sepsis

Indexed keywords

ADRENAL INSUFFICIENCY; ADULT; AGED; CALCITONIN; FEMALE; HUMANS; HYDROCORTISONE; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PLACEBOS; PROTEIN PRECURSORS; SHOCK, SEPTIC; TREATMENT OUTCOME;

EID: 84905040779     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: 10.7754/Clin.Lab.2013.130636     Document Type: Article

References (34)

1. Nijsten MW, Olinga P, The TH, de Vries EG, Koops HS, Groothuis GM, et al. Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro. Crit Care Med 2000 Feb;28(2):458-61. (Pubitemid 30120889)
2. Meisner M. Pathobiochemistry and clinical use of procalcitonin. Clin Chim Acta 2002 Sep;323(1-2):17-29. (Pubitemid 34804792)
3. Morgenthaler NG, Struck J, Chancerelle Y, et al. Production of procalcitonin (PCT) in non-thyroidal tissue after LPS injection. Horm Metab Res 2003 May;35(5):290-5. (Pubitemid 37011514)
4. Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 2006 Jul;34(7):1996-2003. (Pubitemid 43982479)
5. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 2004 Jul 15;39(2):206-17. (Pubitemid 38971491)
6. Clec'h C, Fosse JP, Karoubi P, et al. Differential diagnostic value of procalcitonin in surgical and medical patients with septic shock. Crit Care Med 2006 Jan;34(1):102-7. (Pubitemid 43032386)
7. Hatherill M, Jones G, Lim E, Tibby SM, Murdoch IA. Procalcitonin aids diagnosis of adrenocortical failure. Lancet 1997 Dec 13;350(9093):1749-50. (Pubitemid 28036679)
8. Schumm J, Pfeifer R, Ferrari M, Kuethe F, Figulla HR. An unusual case of progressive shock and highly elevated procalcitonin level. Am J Crit Care. Jan;19(1):96-3.
9. Marik PE. Adrenal-exhaustion syndrome in patients with liver disease. Intensive Care Med 2006 Feb;32(2):275-80. (Pubitemid 43251149)
10. Arabi YM, Aljumah A, Dabbagh O, A, et al. Low-dose hydrocortisone in patients with cirrhosis and septic shock: a randomized controlled trial. CMAJ 2010 Dec 14;182(18):1971-7.
11. Clec'h C, Ferriere F, Karoubi P, et al. Diagnostic and prognostic value of procalcitonin in patients with septic shock. Crit Care Med 2004 May;32(5):1166-9. (Pubitemid 38620986)
12. Boussekey N, Leroy O, Alfandari S, Devos P, Georges H, Guery B. Procalcitonin kinetics in the prognosis of severe community-acquired pneumonia. Intensive Care Med 2006 Mar;32(3):469-72. (Pubitemid 43289660)
13. Boussekey N, Leroy O, Georges H, Devos P, d'Escrivan T, Guery B. Diagnostic and prognostic values of admission procalcitonin levels in community-acquired pneumonia in an intensive care unit. Infection 2005 Aug;33(4):257-63. (Pubitemid 41152186)
14. Luyt CE, Guerin V, Combes A, et al. Procalcitonin kinetics as a prognostic marker of ventilator-associated pneumonia. Am J Respir Crit Care Med 2005 Jan 1;171(1):48-53. (Pubitemid 40051694)
15. Rau BM, Kemppainen EA, Gumbs AA, et al. Early assessment of pancreatic infections and overall prognosis in severe acute pancreatitis by procalcitonin (PCT): a prospective international multicenter study. Ann Surg 2007 May;245(5):745-54. (Pubitemid 46684104)
16. Rau BM, Frigerio I, Buchler MW, et al. Evaluation of procalcitonin for predicting septic multiorgan failure and overall prognosis in secondary peritonitis: a prospective, international multicenter study. Arch Surg 2007 Feb;142(2):134-42. (Pubitemid 46294132)
17. Arabi Y, Alshimemeri A, Taher S. Weekend and weeknight admissions have the same outcome of weekday admissions to an intensive care unit with onsite intensivist coverage. Crit Care Med 2006 Mar;34(3):605-11.
18. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985 Oct;13(10):818-29. (Pubitemid 15250137)
19. Ferreira FL, Bota DP, Bross A, Melot C, Vincent JL. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 2001 Oct 10;286(14):1754-8. (Pubitemid 33010262)
20. Marik PE, Pastores SM, Annane D, et al. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med 2008 Jun;36(6):1937-49.
21. Muller B, Becker KL, Schachinger H, et al. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med 2000 Apr;28(4):977-83. (Pubitemid 30262065)
22. Harbarth S, Holeckova K, Froidevaux C, et al. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 2001 Aug 1;164(3):396-402. (Pubitemid 32778205)
23. Elefsiniotis IS, Skounakis M, Vezali E, et al. Clinical significance of serum procalcitonin levels in patients with acute or chronic liver disease. Eur J Gastroenterol Hepatol 2006 May;18(5):525-30. (Pubitemid 43832753)
24. Bewick V, Cheek L, Ball J. Statistics review 13: receiver operating characteristic curves. Critical care 2004 Dec;8(6):508-12. (Pubitemid 40073688)
25. Marik PE, Gayowski T, Starzl TE. The hepatoadrenal syndrome: a common yet unrecognized clinical condition. Crit Care Med 2005 Jun;33(6):1254-9. (Pubitemid 40827374)
26. Tsai MH, Peng YS, Chen YC, et al. Adrenal insufficiency in patients with cirrhosis, severe sepsis and septic shock. Hepatology 2006 Apr;43(4):673-81.
27. Jaattela M, Ilvesmaki V, Voutilainen R, Stenman UH, Saksela E. Tumor necrosis factor as a potent inhibitor of adrenocorticotropin-induced cortisol production and steroidogenic P450 enzyme gene expression in cultured human fetal adrenal cells. Endocrinology 1991 Jan;128(1):623-9.
28. Bota DP, Van Nuffelen M, Zakariah AN, Vincent JL. Serum levels of C-reactive protein and procalcitonin in critically ill patients with cirrhosis of the liver. J Lab Clin Med 2005 Dec;146(6):347-51. (Pubitemid 41712021)
29. Fernandez J, Gustot T. Management of bacterial infections in cirrhosis. J Hepatol 2012;56 Suppl 1:S1-12.
30. Spahr L, Morard I, Hadengue A, Vadas L, Pugin J. Procalcitonin is not an accurate marker of spontaneous bacterial peritonitis in patients with cirrhosis. Hepatogastroenterology.2001 Mar-Apr;48(38):502-5. (Pubitemid 32391600)
31. Viallon A, Zeni F, Pouzet V, et al. Serum and ascitic procalcitonin levels in cirrhotic patients with spontaneous bacterial peritonitis: diagnostic value and relationship to pro-inflammatory cytokines. Intensive Care Med 2000 Aug;26(8):1082-8.
32. Connert S, Stremmel W, Elsing C. Procalcitonin is a valid marker of infection in decompensated cirrhosis. Z Gastroenterol 2003 Feb;41(2):165-70. (Pubitemid 36313736)
33. Li CH, Yang RB, Pang JH, et al. Procalcitonin as a biomarker for bacterial infections in patients with liver cirrhosis in the emergency department. Acad Emerg Med 2011 Feb;18(2):121-6.
34. Bouadma L, Luyt CE, Tubach F, et al. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet 2010 Feb 6;375(9713):463-74.